4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-052221
President, R&D sold 8,000 shares at $22.43 ($179,440)
- President, R&D acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-10-03 | Option exercise | +8,000 | $4.12 | $32,960 | 96,683 | D: show line 1 in the form |
| Bergstrom Donald A President, R&D | 2022-10-03 | Sale | −8,000 | $22.43 | $179,440 | 88,683 | D: show line 2 in the form |
| Open-market sales · 8,000 sh · avg $22.43 · $179,440 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-10-03 | Option exercise · Stock Option (Right to Buy) | −8,000 | 101,456 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…